Altern Ther Health Med. 2024 Aug;30(8):152-157.
This study aims to explore the predictive value of preoperative C-reactive protein (CRP) and other inflammatory biomarkers: platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) for postoperative complications (infection, diarrhea, etc.) in colorectal tumor patients.
A cohort of 109 colorectal tumor patients who underwent surgical resection for colorectal cancer at the hospital from January 2021 to December 2022 were selected as the research subjects. Patients' postoperative complications were tracked, and they were split into the complication group and the non-complication group. All patients underwent preoperative biochemical tests. Serum levels of CRP, PLR, and NLR were compared between the two groups. The relationship between these markers and postoperative complications in colorectal tumor patients was analyzed. A Logistic regression model was established to analyze their impact on postoperative complications, and a Receiver Operating Characteristic (ROC) curve was drawn to assess predictive value.
Among the 109 colorectal tumor patients, 31 cases (28.44%) experienced postoperative complications. The complication group had larger tumor diameters and a higher proportion of open surgeries compared to the non-complication group (P < .05). Serum levels of CRP, PLR, and NLR were higher in the complication group compared to the non-complication group (P < .05). Correlation analysis showed that serum CRP, PLR, and NLR values were positively correlated with postoperative complications in colorectal tumor patients (r > 0, P < .05). The Logistic regression model revealed that high serum CRP levels (95%CI: 1.253-2.503), PLR (95%CI: 1.005-1.041), and NLR values (95%CI: 2.702-20.533) were risk factors for postoperative complications in colorectal tumor patients (OR>1, P < .05). The ROC curve demonstrated that serum CRP levels, PLR, and NLR values had certain predictive values for postoperative complications in colorectal tumor patients (AUC=0.811, 0.789, 0.870), the optimal predictive values were obtained when the cut-off values were set at 5.400 mg/L, 142.790, and 2.485, respectively and combined detection showed even higher predictive values (AUC=0.913). At 1 week post-surgery, the patient's CRP levels, PLR value, and NLR value were significantly lower than pre-surgery (P < .05).
Preoperative serum CRP, PLR, and NLR values are closely related to postoperative complications in colorectal tumor patients, and they can be used to predict the risk of postoperative complications in colorectal tumor patients. Clinically, early prediction of postoperative complications in patients can be achieved by measuring the aforementioned indicators, allowing for the implementation of appropriate preventive measures such as detoxification and infection control to improve patient outcomes.
本研究旨在探讨术前 C 反应蛋白(CRP)和其他炎症生物标志物(血小板与淋巴细胞比值 [PLR]和中性粒细胞与淋巴细胞比值 [NLR])对结直肠肿瘤患者术后并发症(感染、腹泻等)的预测价值。
选取 2021 年 1 月至 2022 年 12 月在我院接受结直肠癌手术切除的 109 例结直肠肿瘤患者为研究对象。跟踪患者术后并发症情况,并将其分为并发症组和非并发症组。所有患者均进行术前生化检查。比较两组患者的 CRP、PLR 和 NLR 血清水平。分析这些标志物与结直肠肿瘤患者术后并发症的关系。建立 Logistic 回归模型分析其对术后并发症的影响,并绘制受试者工作特征(ROC)曲线评估预测价值。
在 109 例结直肠肿瘤患者中,31 例(28.44%)发生术后并发症。并发症组的肿瘤直径较大,且开腹手术比例高于非并发症组(P<.05)。并发症组的 CRP、PLR 和 NLR 血清水平均高于非并发症组(P<.05)。相关性分析显示,结直肠肿瘤患者 CRP、PLR 和 NLR 血清值与术后并发症呈正相关(r>0,P<.05)。Logistic 回归模型显示,高水平的 CRP(95%CI:1.253-2.503)、PLR(95%CI:1.005-1.041)和 NLR 值(95%CI:2.702-20.533)是结直肠肿瘤患者术后并发症的危险因素(OR>1,P<.05)。ROC 曲线表明,CRP 水平、PLR 和 NLR 值对结直肠肿瘤患者术后并发症具有一定的预测价值(AUC=0.811、0.789、0.870),当截断值分别设定为 5.400mg/L、142.790 和 2.485 时,可获得最佳预测值,联合检测显示出更高的预测价值(AUC=0.913)。术后 1 周时,患者的 CRP 水平、PLR 值和 NLR 值均明显低于术前(P<.05)。
结直肠肿瘤患者术前血清 CRP、PLR 和 NLR 值与术后并发症密切相关,可用于预测结直肠肿瘤患者术后并发症的风险。临床上,通过测量上述指标可以早期预测患者术后并发症,从而实施适当的预防措施,如解毒和感染控制,以改善患者的预后。